Eroica Dx is developing rapid, point-of-care diagnostic devices based on nanophotonic biosensors to identify bacterial pathogens and key antimicrobial resistance (AMR) markers directly from a small blood sample in under 30 minutes.
Additional Information
Eroica Dx
- Creation year:
2025
- Web:
- Involved research groups:
- ICN2 researchers involved: